ストックスクリーナーアプリを入手
5.83
8.97%
0.48
アフターアワーズ：
5.88
0.05
+0.86%
Savara Inc (SVRA) 最新ニュース
Savara (NASDAQ:SVRA) Shares Up 6.8%Here's Why - MarketBeat
Growth Value: Is Savara Inc being accumulated by smart moneyEarnings Trend Report & Verified Trade Idea Suggestions - baoquankhu1.vn
Savara Insiders Added US$535.6k Of Stock To Their Holdings - Yahoo Finance
Savara Secures Path to $150M as FDA Decision Nears for Rare Lung Drug - MyChesCo
Savara Announces Participation in Upcoming February 2026 Investor Healthcare Conferences - BioSpace
Savara Inc. (NASDAQ:SVRA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Savara Announces Participation in Upcoming Investor Healthcare Conferences - ChartMill
Savara Inc. Launches Convenient DBS Test for Diagnosing Rare Lung Disease - MSN
Savara (NASDAQ:SVRA) Trading 2.5% HigherShould You Buy? - MarketBeat
Expanded Hercules Credit Line Tied To MOLBREEVI Approval Could Be A Game Changer For Savara (SVRA) - simplywall.st
ETF Watch: Why is Savara Inc stock going downQuarterly Performance Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Savara grants equity awards to new hires as it advances rare lung drug - MSN
Growth Report: Is Savara Inc being accumulated by smart moneyQuarterly Profit Review & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Movement Recap: Will Savara Inc announce a stock splitStock Surge & AI Enhanced Execution Alerts - baoquankhu1.vn
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI - BioSpace
Savara secures additional $75m in debt financing for potential drug launch - Investing.com Australia
Hercules Capital Ties Savara Funding To FDA Milestone And Valuation Case - simplywall.st
A Look At Hercules Capital (HTGC) Valuation After The Expanded Savara Loan Agreement - Yahoo Finance
Savara Reports Amendment to Hercules Capital Debt Facility - marketscreener.com
Savara amends loan agreement to access up to $105 million in term loans - Investing.com Nigeria
Savara Grants Equity Awards to New Hires as It Advances Rare Lung Drug - MyChesCo
How Investors May Respond To Savara (SVRA) Adding Approval-Linked Hercules Credit To Its Liquidity Toolkit - simplywall.st
Savara Ekes up on Deal with Hercules - Baystreet.ca
Savara amends loan agreement to access up to $105 million in term loans By Investing.com - Investing.com South Africa
Savara Enters New Material Definitive Agreement and Obligation - TipRanks
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI* - Business Wire
Savara (SVRA) Faces Class Action Lawsuit Over Shareholder Losses - Intellectia AI
SAVARA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Savara, Inc. (SVRA) Stock Analysis: Exploring a 67% Potential Upside in Rare Respiratory Disease Biotech - DirectorsTalk Interviews
CEO Moves: Does Star Equity Holdings Inc have a competitive edgeLong Setup & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Rare lung drug nears FDA decision as PANTHERx, Savara seal US deal - MSN
Rare Lung Drug Nears FDA Decision as PANTHERx, Savara Seal U.S. Deal - mychesco.com
Savara Secures $75 Million Royalty Deal to Back Potential MOLBREEVI Launch - MSN
FDA clock restarts: Savara refiles MOLBREEVI for rare lung disease - MSN
Day Trade: What is the dividend yield of LIVEJuly 2025 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
Aug Opening: Should I trade or invest in Savara Inc2025 Institutional Moves & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Savara Announces New Employment Inducement Grant - Business Wire
What Savara (SVRA)'s Exclusive PANTHERx MOLBREEVI Distribution Deal Means For Shareholders - simplywall.st
Aug Opening: Will Savara Inc benefit from government policyRate Cut & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Savara Reports 2024 Financial Results and Provides Updates on MOLBREEVI Progress - MSN
Value Recap: Can Savara Inc disrupt its industryJobs Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
Savara Highlights Autoimmune PAP Burden in Updated Presentation - TipRanks
Lobbying Update: $30,000 of SAVARA INC. lobbying was just disclosed | SVRA Stock News - Quiver Quantitative
With 37% stake, Savara Inc. (NASDAQ:SVRA) seems to have captured institutional investors' interest - Yahoo Finance
Savara Inc. (NASDAQ:SVRA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Savara Inc. Announces Equity Awards for New Employees - MSN
Savara Inc. Grants Inducement Awards to New Employees with Stock Options & RSUs - msn.com
How big funds are accumulating Savara Inc. (YB4P) stock2025 Price Action Summary & Capital Protection Trade Alerts - Улправда
Why Savara Inc. stock is favored by top institutions2025 Stock Rankings & Growth Focused Entry Reports - ulpravda.ru
How Savara Inc. stock compares to growth peers2025 Institutional Moves & AI Optimized Trading Strategy Guides - Улправда
The Bull Case For Savara (SVRA) Could Change Following Exclusive MOLBREEVI Distribution Deal With PANTHERx - simplywall.st
Market Fear: Will Savara Inc. stock outperform growth indexesMarket Risk Analysis & Smart Swing Trading Alerts - Улправда
How Savara Inc. stock benefits from global expansionJuly 2025 Movers & Fast Gaining Stock Strategy Reports - Улправда
Will Savara Inc. stock outperform growth indexes2025 Market WrapUp & AI Powered Market Trend Analysis - ulpravda.ru
Will Savara Inc. stock outperform tech sector in 20252025 Price Momentum & Daily Price Action Insights - Улправда
How Savara Inc. (YB4P) stock compares with top peersProduct Launch & Technical Confirmation Alerts - Улправда
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):